In a paper published today in Nature Synthesis, a team from the lab of University of Chicago Pritzker School of Molecular Engineering (UChicago PME) and Chemistry Department Prof. Paul Alivisatos ...
2d
Researchers discover chemical reaction that opens new avenues in drug development, protein science
Researchers unveil a groundbreaking chemical reaction for efficient drug development and protein science by manipulating ...
The new reaction enables selective modification of anti-cancer drugs, rapid synthesis of medicinal compounds, and production of recyclable polymers, enhancing drug and materials science.
Researchers have discovered a new chemical reaction that spontaneously makes and breaks a sulphur-sulphur bond at room ...
In a paper published today in Nature Synthesis, a team from the lab of University of Chicago Pritzker School of Molecular Engineering (UChicago PME) and Chemistry Department Prof. Paul ...
In a paper published today in Nature Synthesis , a team from the lab of University of Chicago Pritzker School of Molecular Engineering (UChicago PME ...
A 3D model of a sheet of hydrocarbon chains that form a honeycomb pattern. Each side of the honeycomb contains three benzene rings with short linkers between them. A new covalent organic framework is ...
Roche announces FENhance 1 phase III study of fenebrutinib for relapsing and primary progressive MS meets its primary endpoint: Basel Wednesday, March 4, 2026, 14:00 Hrs [IST] Roc ...
FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing multiple sclerosis (RMS), consistent with ...
FENhance 1 met its primary endpoint, showing investigational fenebrutinib significantly reduced relapses by 51% compared to teriflunomide in relapsing multiple sclerosis (RMS), consistent with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results